ALKS
ALKS
NASDAQ · Biotechnology

Alkermes Plc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$48.07
+2.05 (+4.45%)
As of Jun 23, 9:52 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 19 83%
Hold 4 17%
Sell 0 0%
Price Target
Analyst Price Target +162.9% upside
Low Target $90.34
Average Target $126.40
High Target $146.79
Current Price $48.07
Current
$48.07
Target
$126.40
$90.34 $126.40 avg $146.79
Scenario Analysis
Bear Case
$90.34
87.9%
Low target
Base Case
$126.40
+162.9%
Avg target
Bull Case
$146.79
+205.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$45.76
5.0% from high
52-Week Low
$25.17
+91.0% from low
50-Day SMA
$31.02
+55.0% vs SMA
200-Day SMA
$29.87
+60.9% vs SMA
RSI (14)
32.3
Neutral
Target vs 52W High
$126.40
+176.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%